Mad Cow Disease

Mad Cow Disease
Public domain · source
Name	Mad Cow Disease
Synonyms	Bovine spongiform encephalopathy
Field	Neurology, Veterinary medicine, Infectious disease
Symptoms	Behavioral changes, ataxia, weight loss
Complications	Neurodegeneration, death
Onset	Months to years
Duration	Progressive, terminal
Causes	Misfolded prion proteins
Risks	Feeding practices, contaminated feed, blood products
Diagnosis	Histopathology, Western blot, immunoassay
Prevention	Feed bans, surveillance, culling
Frequency	Sporadic, epidemic outbreaks

Mad Cow Disease

Mad Cow Disease is a progressive neurodegenerative disorder of cattle classified as bovine spongiform encephalopathy. It belongs to the family of transmissible spongiform encephalopathies and is characterized by spongiform changes in brain tissue, behavioral abnormalities, and fatal outcomes. International responses have involved veterinary agencies, public health institutions, trade authorities, and scientific consortia.

Overview

Bovine spongiform encephalopathy was first recognized in the context of intensive livestock production and became a focus for agencies such as the World Health Organization, Food and Agriculture Organization, European Commission, United States Department of Agriculture, and national veterinary services. Concerns prompted action from institutions like the Wellcome Trust, European Food Safety Authority, Medical Research Council, Royal Society, and university departments including University of Cambridge, University of Oxford, University College London, and Imperial College London. Responses included collaborations with research centers such as the Pasteur Institute, Max Planck Society, National Institutes of Health, Centers for Disease Control and Prevention, and laboratories within the European Medicines Agency. Policy measures interfaced with trade entities like the World Trade Organization and regulatory frameworks enacted by the Parliament of the United Kingdom, European Parliament, United States Congress, and national ministries of agriculture.

Cause and Pathogenesis

The etiologic agent is an abnormal isoform of the prion protein whose misfolding propagates via a protein-only mechanism characterized by conformational templating. Fundamental research was advanced by investigators affiliated with institutions such as Prion Research Unit, Institute of Animal Health, Cullen Laboratory, Gajdusek Laboratory, Stanley Prusiner Laboratory, Walter and Eliza Hall Institute, Scripps Research, and academic groups at Massachusetts Institute of Technology, Harvard University, Yale University, Johns Hopkins University, and Columbia University. Molecular characterization employed techniques developed at the Cold Spring Harbor Laboratory, Rockefeller University, Lawrence Berkeley National Laboratory, National Institute of Neurological Disorders and Stroke, and commercial firms like Thermo Fisher Scientific and Roche. Pathogenesis studies used animal models maintained in facilities such as Roslin Institute, Wistar Institute, and The Francis Crick Institute. Prion strain typing, proteinase K resistance assays, and histopathology protocols drew on methods from European Brain Bank Network, National Prion Clinic, and reference centers in Canada, Japan, Australia, and New Zealand.

Transmission and Zoonotic Risk

Transmission dynamics involve exposure to infected tissues via feed, iatrogenic routes, or environmental contamination. Feed-related amplification implicated suppliers, rendering controls from bodies like the European Commission Directorate-General for Health and Food Safety, Food Standards Agency, Defra, Canadian Food Inspection Agency, Ministry of Agriculture, Forestry and Fisheries (Japan), and industry groups crucial. Zoonotic concerns mobilized research groups at University of Edinburgh, University of Glasgow, University of Liverpool, University of Bristol, University of Melbourne, and University of Tokyo to investigate links to a human variant recognized by clinicians at the National CJD Surveillance Unit, Health Protection Agency, Public Health England, and hospitals such as St Mary’s Hospital, Addenbrooke's Hospital, Guy's Hospital, and Massachusetts General Hospital. Investigations involved collaborations with the European Centre for Disease Prevention and Control, Public Health Agency of Canada, Australian Department of Health, and the Ministry of Health, Welfare and Sport (Netherlands).

Clinical Signs and Diagnosis

Cattle present with progressive behavioral change, hypersensitivity, incoordination, and decreased milk yield; neurologic assessment protocols were standardized by veterinary colleges including Royal College of Veterinary Surgeons, American Veterinary Medical Association, Royal Veterinary College, and academic clinics at University of California, Davis, Cornell University, Iowa State University, and University of Pennsylvania. Diagnostic confirmation requires neuropathology, immunohistochemistry, Western blot, and bioassay approaches validated by reference laboratories such as OIE Reference Laboratories, Laboratoire National de Santé, National Veterinary Services Laboratories, and university pathology units at University of Bern and University of Helsinki. Differential diagnosis considerations engaged specialists associated with European Society of Veterinary Neurology, International Society for Infectious Diseases, Royal Society of Medicine, and clinical networks like EuroCJD.

Prevention, Control, and Regulation

Control strategies emphasized feed bans, specified risk material removal, slaughter surveillance, and market restrictions enforced by agencies including the European Commission, United States Department of Agriculture, Food and Drug Administration, Canadian Food Inspection Agency, Ministry of Agriculture (France), Federal Office of Consumer Protection and Food Safety (Germany), and regional bodies such as African Union veterinary services and ASEAN committees. Surveillance programs integrated reporting via platforms coordinated by World Organisation for Animal Health, WHO, and national public health institutes such as Robert Koch Institute, Instituto Nacional de Salud Pública (Mexico), Korea Centers for Disease Control and Prevention, and National Institute for Public Health and the Environment (Netherlands). Research on decontamination, rendering practices, and inactivation involved chemical manufacturers and standards organizations like ISO, ASTM International, and laboratories at Sandia National Laboratories and Lawrence Livermore National Laboratory. Economic and trade implications were managed through negotiations at the World Trade Organization and bilateral agreements administered by ministries of trade and agriculture.

History and Notable Outbreaks

Major outbreaks and policy crises in the late 20th century prompted inquiries by the UK Government, inquiries chaired by figures associated with the BSE Inquiry, and parliamentary scrutiny by the House of Commons and House of Lords. Key events involved actions by industry groups such as the National Farmers' Union (UK), processors including Tate & Lyle, and retailers like Tesco, Sainsbury's, Marks & Spencer, and Walmart. International responses featured embargoes and investigations led by delegations from the European Union, United States Department of Agriculture, Canadian Food Inspection Agency, Australian Department of Agriculture and Water Resources, and missions from the World Bank assessing agricultural impacts. Scientific milestones included prion theory development recognized by awards linked to organizations such as the Nobel Committee, and studies published by researchers affiliated with journals and publishers including Nature, Science, The Lancet, BMJ, Proceedings of the National Academy of Sciences, and Cell. Notable national cases and surveillance efforts were reported in United Kingdom, France, Ireland, Spain, Portugal, Switzerland, United States, Canada, Japan, Australia, and New Zealand.

Category:Prion diseases